Cargando…

Therapeutic Advances in Oncology

Around 77 new oncology drugs were approved by the FDA in the past five years; however, most cancers remain untreated. Small molecules and antibodies are dominant therapeutic modalities in oncology. Antibody-drug conjugates, bispecific antibodies, peptides, cell, and gene-therapies are emerging to ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinsha, Pandya, Priyanka, Afshar, Sepideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922397/
https://www.ncbi.nlm.nih.gov/pubmed/33670524
http://dx.doi.org/10.3390/ijms22042008